Alprazolam and Distributive shock - a phase IV clinical study of FDA data

Summary:

Distributive shock is reported as a side effect among people who take Alprazolam (alprazolam), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Pneumonia.

The phase IV clinical study analyzes which people have Distributive shock when taking Alprazolam. It is created by eHealthMe based on reports of 132,238 people who have side effects when taking Alprazolam from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Distributive shock?

Distributive shock (hock caused by poor distribution of the blood flow) is found to be associated with 118 drugs and 123 conditions by eHealthMe. Check the latest studies of Distributive shock.

On Jul, 21, 2026

132,238 people reported to have side effects when taking Alprazolam.
Among them, 57 people (0.04%) have Distributive shock.

Could Alprazolam cause Distributive shock?

Among these 57 people:

How long have people been on Alprazolam when they have Distributive shock? *

What is the gender of people who have Distributive shock when taking Alprazolam? *

female: 40.82 %
male: 59.18 %

What is the age of people who have Distributive shock when taking Alprazolam? *

What are other drugs people take besides Alprazolam? *

Amlodipine: 28 people, 49.12%
Zolpidem: 21 people, 36.84%
Codeine: 18 people, 31.58%
Paracetamol: 12 people, 21.05%
Zopiclone: 10 people, 17.54%
Rivaroxaban: 10 people, 17.54%
Gliclazide: 10 people, 17.54%
Amlodipine Besylate: 8 people, 14.04%
Bupropion Hydrochloride: 5 people, 8.77%
Zolpidem Tartrate: 3 people, 5.26%

What are other side effects people have besides Distributive shock? *

Suicide Attempt: 25 people, 43.86%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 22 people, 38.60%
Renal Papillary Necrosis (a disorder of the kidneys in which all or part of the renal papillae die): 20 people, 35.09%
Hypotension (abnormally low blood pressure): 20 people, 35.09%
Consciousness - Decreased: 20 people, 35.09%
Speech Impairment (Adult) (inability to speak (adult)): 19 people, 33.33%
Respiratory Disorder (respiratory disease): 14 people, 24.56%
Fatigue (feeling of tiredness): 14 people, 24.56%
Liver Injury: 14 people, 24.56%
Delirium (wild excitement): 14 people, 24.56%

What are the existing conditions these people have? *

Pneumonia: 12 people, 21.05%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 15.79%
Suicide Attempt: 8 people, 14.04%
Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 7.02%
Sedation: 2 people, 3.51%
Pneumonia Staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus): 2 people, 3.51%
Delirium (wild excitement): 2 people, 3.51%
Agitation (state of anxiety or nervous excitement): 2 people, 3.51%
Transplant Rejection (a transplant material is not worked): 1 person, 1.75%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 1.75%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and have Distributive shock?

- Check whether Distributive shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprazolam:

Alprazolam (134,864 reports)

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Distributive shock:

Distributive shock (118 drugs)

Browse all the conditions that are associated with Distributive shock:

Distributive shock (123 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam (the active ingredients of Alprazolam) and Alprazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.